Pharmaceutical Manufacturing Company For Sale In Hyderabad

About Business

About the company:

With 35 years of experience in manufacturing and marketing medicines, the company has established itself as a prominent and growing player in the pharmaceutical industry, reflecting its long-standing dedication and expertise.

Here are the main products of the company:

Tablets:
- Antibiotic/Anti-inflammatory Analgesic
- Antidiarrhoeal/Antipyretic/Antihistamine
- Nutraceutical

Ear Drops:
- Waxolytic
- Proton Pump Inhibitor + GI Prokinetic
- Antacid/Antiflatulent Suspension

Syrups:
- Bronchodilator/Antidigestive Syrup
- Carminative/Digestive Enzymes Oral Drops

Topical Products:
- Anti-inflammatory Analgesic Gel
- Antiseptic Ointment


The manufacturing facility is owned and situated at nearby Vijayawada, Andhra Pradesh. Location & Size: Situated near Vijayawada, Andhra Pradesh. The size of the facility is 1 acre with 45,000 square feet of constructed area.

Clientele type

Below are some of the major clients of the company.

Apollo Hospitals: A well-known hospital chain in India.
Yashoda Hospitals: Another major hospital group in India.
St. John's Hospital, Bangalore: A prominent hospital in Bangalore.
Manipal Hospitals: A large healthcare group in India.
Sancheti Hospital: Known for orthopedics and related specialties.
Amrita Hospitals, Kochi: A multi-specialty hospital in Kochi.
Central India Institute of Medical Sciences (CIIMS): A medical institute in central India.

Premises

OWNED

Premise Size: 45000 Sq. Ft.

Market Value (in INR): 5.00 Cr

Asking Price Includes

The founder is looking to sell the entire business.

Reason

The founder is looking to exit the business as part of a succession plan, with the intention of passing the business on to a young and passionate individual.

More Details

The founder, a BITS Pilani graduate, brings a wealth of knowledge and experience to the pharmaceutical sector.

Currently, the company is a well-established pharmaceutical entity with 500 dedicated field professionals across the country and a turnover of 500 million.

As one of the pioneers in the field, the company played a key role in popularizing the concept of dispersible tablets (Distabs).

Holding an ISO-9001:2000 certification from American Quality Assessors (AQA), accredited by ANSI-RAB (2000), the company upgraded its certification to ISO-9001:2000 in 2004.

In 2003, the company introduced ECGC technology and achieved a significant milestone by stabilizing 23 ingredients in sugar-coated tablet form by 2005.